Want to see IN:TATVA full AI Analyst Report?
TATVA Stock Chart & Stats
₹1388.35
-₹14.30(-1.60%)
At close: 4:00 PM EST
₹1388.35
-₹14.30(-1.60%)
Day’s Range― - ―
52-Week Range₹915.50 - ₹1,603.60
Previous CloseN/A
Volume13.99K
Average Volume (3M)12.52K
Market Cap
₹33.13B
Enterprise Value₹25.70K
Total Cash (Recent Filing)₹87.91M
Total Debt (Recent Filing)₹1.20B
Price to Earnings (P/E)78.9
Beta1.11
Next Earnings
Jul 17, 2026EPS Estimate
6.05Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)17.98
Shares Outstanding23,392,056
10 Day Avg. Volume25,333
30 Day Avg. Volume12,516
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)3.15
Price to Sales (P/S)4.87
P/FCF Ratio-29.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)31
Revenue Forecast (FY)₹6.38B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageA large equity base versus modest debt provides solvency and financial flexibility over the medium term. This strengthens the firm's ability to fund customer qualification cycles, capex and working-capital needs without immediate refinancing pressure, supporting durability through cycles.
Diversified Specialty-chemicals Exposure Incl. Battery SaltsProduct mix spans PTCs, pharma/agro intermediates and electrolyte salts, giving exposure to secular battery demand and recurring industrial customers. Diversification across end markets reduces single-industry dependency and supports steadier demand over months to years.
Recent Revenue Recovery TrendA meaningful revenue rebound signals recovering end-market demand and better utilization of capabilities. If sustained, rising top-line can restore operating leverage, improve margin sustainability and help convert investments into durable earnings traction over several quarters.
Bears Say
Persistent Negative Free Cash FlowConsistent negative FCF indicates cash generation lags reported profits, implying heavy reinvestment or working-capital strain. This raises reliance on the balance sheet or external funding, constraining capital allocation and making earnings recovery less durable until FCF turns positive.
Volatile Profitability And Below-peak EarningsLarge swings in operating profit and earnings reduce forecasting confidence and signal exposure to cost/price dynamics. Persistent volatility undermines margin sustainability and makes it harder to justify incremental investments until margins stabilize across cycles.
Step-up In Debt In Latest YearA rise in leverage after prior improvement increases interest and refinancing risk, particularly given negative FCF. Higher debt can limit strategic flexibility and amplify downside if returns on incremental capital fail to materialize over the next several quarters.
Tatva Chintan Pharma Chem Limited News
TATVA FAQ
What was Tatva Chintan Pharma Chem Limited’s price range in the past 12 months?
Tatva Chintan Pharma Chem Limited lowest stock price was ₹915.50 and its highest was ₹1603.60 in the past 12 months.
What is Tatva Chintan Pharma Chem Limited’s market cap?
Tatva Chintan Pharma Chem Limited’s market cap is ₹33.13B.
When is Tatva Chintan Pharma Chem Limited’s upcoming earnings report date?
Tatva Chintan Pharma Chem Limited’s upcoming earnings report date is Jul 17, 2026 which is today.
How were Tatva Chintan Pharma Chem Limited’s earnings last quarter?
Currently, no data Available
Is Tatva Chintan Pharma Chem Limited overvalued?
According to Wall Street analysts Tatva Chintan Pharma Chem Limited’s price is currently Overvalued.
Does Tatva Chintan Pharma Chem Limited pay dividends?
Tatva Chintan Pharma Chem Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.07%. See more information on Tatva Chintan Pharma Chem Limited dividends here
What is Tatva Chintan Pharma Chem Limited’s EPS estimate?
Tatva Chintan Pharma Chem Limited’s EPS estimate is 6.05.
How many shares outstanding does Tatva Chintan Pharma Chem Limited have?
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding.
What happened to Tatva Chintan Pharma Chem Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tatva Chintan Pharma Chem Limited?
Currently, no hedge funds are holding shares in IN:TATVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited, an Indian-based enterprise, specializes in the production and distribution of diverse specialty chemicals. Its extensive product range encompasses essential components like structure-directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts vital for supercapacitor batteries. Furthermore, the company supplies pharmaceutical active pharmaceutical ingredients (APIs), agrochemical formulations, and various other specialized chemical products, including intermediates, disinfectants, catalytic agents, and solvents. Beyond manufacturing, Tatva Chintan engages in the trading of specialty chemicals and offers quaternary compounds (quats) and bulk drug substances. The firm's clientele spans a broad spectrum of sectors, such as the automotive, petrochemical, pharmaceutical, agricultural chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance industries. Its global reach extends to approximately 25 nations, where its products are exported. Established in 1996, Tatva Chintan Pharma Chem Limited maintains its corporate headquarters in Vadodara, India.
Technical Analysis
AARTI Industries Ltd
―
Alkyl Amines Chemicals Limited
―
Jubilant Ingrevia Ltd.
―
Rossari Biotech Ltd
―
Vinati Organics Limited
―